Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Granisetron hydrochloride |
Is a |
False |
Granisetron (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing granisetron (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Granisetron (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
granisétron 1 mg/mL, ampoule de 3 mL de concentré pour injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Granisetron (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Granisetron (as granisetron hydrochloride) 1 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Granisetron (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
granisétron 1 mg/1 mL, solution intraveineuse |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Granisetron (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Granisetron 200micrograms/mL pediatric liquid (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Granisetron (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Granisetron 2mg tablet (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Granisetron (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Granisetron hydrochloride 1mg/1mL injection solution 1mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Granisetron (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Granisetron hydrochloride 1mg/1mL injection solution 4mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Granisetron (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Granisetron 0.1mg/mL injection solution 1mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Granisetron (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing granisetron in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Granisetron (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing granisetron in parenteral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Granisetron (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Granisetron 3.1mg/24hours transdermal patch |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Granisetron (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Granisetron (as granisetron hydrochloride) 1 mg oral tablet |
Has basis of strength substance (attribute) |
True |
Granisetron (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Granisetron 2mg tablet (substance) |
Has basis of strength substance (attribute) |
True |
Granisetron (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Granisetron hydrochloride |
Is modification of (attribute) |
True |
Granisetron (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Granisetron-containing product in transdermal dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Granisetron (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely granisetron 129.167 microgram/1 hour prolonged-release transdermal patch (clinical drug) |
Has precise active ingredient |
True |
Granisetron (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely granisetron 129.167 microgram/1 hour prolonged-release transdermal patch (clinical drug) |
Has basis of strength substance (attribute) |
True |
Granisetron (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely granisetron (as granisetron hydrochloride) 200 microgram/1 milliliter conventional release oral solution (clinical drug) |
Has basis of strength substance (attribute) |
True |
Granisetron (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely granisetron (as granisetron hydrochloride) 3 milligram/3 milliliter conventional release solution for injection ampule |
Has basis of strength substance (attribute) |
False |
Granisetron (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely granisetron (as granisetron hydrochloride) 1 milligram/1 milliliter conventional release solution for injection ampule |
Has basis of strength substance (attribute) |
False |
Granisetron (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Granisetron only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Granisetron (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing only granisetron in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Granisetron (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Granisetron only product in parenteral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Granisetron (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Granisetron only product in transdermal dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Granisetron (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Granisetron (as granisetron hydrochloride) 1 mg/mL solution for injection |
Has basis of strength substance (attribute) |
True |
Granisetron (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |